Skip to main content

Cancer Genetics' Focus::Lymphoma Panel

Cancer Genetics has launched Focus::Lymphoma, a CLIA-validated, next-generation sequencing panel to detect and monitor the most common mature B-cell lymphomas. The panel enables the targeted sequencing of 220 genes and has the ability to customize the reporting that provides clinically actionable information to determine patients' treatment options. The product can detect mutations in genes such as BTK and PLCG2, which have been recently attributed to therapy resistance, and offers information on genes such as MT2D, which is frequently mutated in B-cell lymphomas, but is not currently available through other commercial platforms.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.